These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Emerging muscarinic receptor antagonists for the treatment of asthma. Matera MG; Belardo C; Rinaldi M; Rinaldi B; Cazzola M Expert Opin Emerg Drugs; 2020 Jun; 25(2):123-130. PubMed ID: 32312134 [TBL] [Abstract][Full Text] [Related]
3. Muscarinic antagonists in early stage clinical development for the treatment of asthma. Albertson TE; Chenoweth JA; Adams JY; Sutter ME Expert Opin Investig Drugs; 2017 Jan; 26(1):35-49. PubMed ID: 27927039 [TBL] [Abstract][Full Text] [Related]
4. Tiotropium – what role in asthma? Drug Ther Bull; 2015 Sep; 53(9):102-4. PubMed ID: 26358316 [TBL] [Abstract][Full Text] [Related]
5. Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management. Kaplan A; FitzGerald JM; Buhl R; Vogelberg C; Hamelmann E NPJ Prim Care Respir Med; 2020 Nov; 30(1):50. PubMed ID: 33177503 [TBL] [Abstract][Full Text] [Related]
6. New and developing non-adrenoreceptor small molecule drugs for the treatment of asthma. Thomson NC Expert Opin Pharmacother; 2017 Feb; 18(3):283-293. PubMed ID: 28099820 [TBL] [Abstract][Full Text] [Related]
7. Emerging role of long acting muscarinic antagonists for asthma. Lipworth BJ Br J Clin Pharmacol; 2014 Jan; 77(1):55-62. PubMed ID: 23534447 [TBL] [Abstract][Full Text] [Related]
8. The reality of LAMAs for adult asthmatic patients. Luz MI; Aguiar R; Morais-Almeida M Expert Rev Respir Med; 2020 Nov; 14(11):1087-1094. PubMed ID: 32687426 [TBL] [Abstract][Full Text] [Related]
9. Long-acting muscarinic receptor antagonists for the treatment of respiratory disease. Cazzola M; Page C; Matera MG Pulm Pharmacol Ther; 2013 Jun; 26(3):307-17. PubMed ID: 23274274 [TBL] [Abstract][Full Text] [Related]
10. New perspectives on the role of muscarinic antagonists in asthma therapy. Matera MG; Belardo C; Rinaldi M; Rinaldi B; Cazzola M Expert Rev Respir Med; 2020 Aug; 14(8):817-824. PubMed ID: 32316778 [TBL] [Abstract][Full Text] [Related]
11. Safety of tiotropium in patients with asthma. Dusser D; Ducharme FM Ther Adv Respir Dis; 2019; 13():1753466618824010. PubMed ID: 30795731 [TBL] [Abstract][Full Text] [Related]
12. Role of muscarinic antagonists in asthma therapy. Cazzola M; Ora J; Rogliani P; Matera MG Expert Rev Respir Med; 2017 Mar; 11(3):239-253. PubMed ID: 28140686 [TBL] [Abstract][Full Text] [Related]
13. Tiotropium in the add-on treatment of asthma in adults: clinical trial evidence and experience. Vogelberg C Ther Adv Respir Dis; 2016 Dec; 10(6):525-533. PubMed ID: 27612491 [TBL] [Abstract][Full Text] [Related]
14. Long-acting muscarinic antagonists: a potential add-on therapy in the treatment of asthma? Busse WW; Dahl R; Jenkins C; Cruz AA Eur Respir Rev; 2016 Mar; 25(139):54-64. PubMed ID: 26929422 [TBL] [Abstract][Full Text] [Related]
15. Tiotropium Bromide in Children and Adolescents with Asthma. Raissy HH; Kelly HW Paediatr Drugs; 2017 Dec; 19(6):533-538. PubMed ID: 28808948 [TBL] [Abstract][Full Text] [Related]
16. Anticholinergics for asthma: a long history. Rodrigo GJ Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):38-43. PubMed ID: 29040210 [TBL] [Abstract][Full Text] [Related]
17. Tiotropium in asthma: From bench to bedside. Mansfield L; Bernstein JA Respir Med; 2019; 154():47-55. PubMed ID: 31212121 [TBL] [Abstract][Full Text] [Related]
19. Tiotropium for the treatment of asthma: a drug safety evaluation. Kerstjens HA; O'Byrne PM Expert Opin Drug Saf; 2016 Aug; 15(8):1115-24. PubMed ID: 27279414 [TBL] [Abstract][Full Text] [Related]
20. Emerging therapeutic options for the treatment of patients with symptomatic asthma. McIvor RA Ann Allergy Asthma Immunol; 2015 Oct; 115(4):265-271.e5. PubMed ID: 26254973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]